{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 449590785
| IUPAC_name = 4-imino-1,3-diazabicyclo[3.1.0]hexan-2-one
| image = Imexon.svg

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 59643-91-3
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 68791
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 8F63U28T2V
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08932
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 62031


<!--Chemical data-->
| C=4 | H=5 | N=3 | O=1 
| molecular_weight = 111.102 g/mol
| smiles            = O=C1/N=C(/N)C2N1C2
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI          = 1S/C4H5N3O/c5-3-2-1-7(2)4(8)6-3/h2H,1H2,(H2,5,6,8)
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey       = BIXBBIPTYBJTRY-UHFFFAOYSA-N
}}
'''Imexon''' ([[International Nonproprietary Name|INN]], trade name '''Amplimexon''') is a [[Chemical substance|substance]] that is being studied in the treatment of some types of [[cancer]], including [[pancreatic]], [[lung]], [[breast]], [[prostate]], [[melanoma]], and [[multiple myeloma]]. It is a [[cyanoaziridine]] derivative.

== External links ==
* [http://www.cancer.gov/dictionary?CdrID=513068 Amplimexon] entry in the public domain NCI Dictionary of Cancer Terms

{{NCI-cancer-dict}}

[[Category:Experimental cancer drugs]]


{{antineoplastic-drug-stub}}